NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.9800
-0.0200 (-2.00%)
Sep 30, 2025, 2:45 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 80.77 million as of October 1, 2025. Its market cap has increased by 106.33% in one year.
Market Cap
80.77M
Enterprise Value
79.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 80.77M, an increase of 141.21%. That is a compound annual growth rate of 30.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 80.77M | 83.75% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.41B |
| Green Thumb Industries | 2.72B |
| Trulieve Cannabis | 2.29B |
| dentalcorp Holdings | 2.16B |
| Sienna Senior Living | 1.74B |
| Cronos Group | 1.58B |
| WELL Health Technologies | 1.31B |
| Extendicare | 1.27B |